KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Non-Current Debt (2019 - 2025)

Evolent Health has reported Non-Current Debt over the past 7 years, most recently at $970.5 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $970.5 million for Q4 2025, up 97.86% from a year ago — trailing twelve months through Dec 2025 was $970.5 million (up 97.86% YoY), and the annual figure for FY2025 was $970.5 million, up 97.86%.
  • Non-Current Debt for Q4 2025 was $970.5 million at Evolent Health, down from $1.1 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for EVH hit a ceiling of $1.1 billion in Q3 2025 and a floor of $202.1 million in Q1 2021.
  • Median Non-Current Debt over the past 5 years was $597.5 million (2023), compared with a mean of $514.9 million.
  • Biggest five-year swings in Non-Current Debt: decreased 18.1% in 2021 and later soared 123.74% in 2023.
  • Evolent Health's Non-Current Debt stood at $215.7 million in 2021, then skyrocketed by 91.48% to $413.0 million in 2022, then skyrocketed by 44.57% to $597.0 million in 2023, then decreased by 17.84% to $490.5 million in 2024, then surged by 97.86% to $970.5 million in 2025.
  • The last three reported values for Non-Current Debt were $970.5 million (Q4 2025), $1.1 billion (Q3 2025), and $648.5 million (Q2 2025) per Business Quant data.